Creative Financial Designs’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Creative Financial Designs’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$462K	Sell	10,560 -1,564	-13%	-$72.3K	0.03%	349
2025 Q4	$551K	Buy	12,124 +481	+4%	+$21.3K	0.03%	317
2025 Q3	$452K	Buy	11,643 +6,068	+109%	+$220K	0.03%	342
2025 Q2	$188K	Buy	5,575 +2,589	+87%	+$82K	0.01%	504
2025 Q1	$94.9K	Buy	+2,986	New	+$113K	0.01%	633
2024 Q3	–	Sell	-56	Closed	-$2.32K	–	1701
2024 Q2	$2.32K	Sell	56 -36	-39%	-$1.5K	﹤0.01%	1464
2024 Q1	$4.2K	Hold	92	–	–	﹤0.01%	1347
2023 Q4	$4.26K	Sell	92 -46	-33%	-$1.88K	﹤0.01%	1288
2023 Q3	$5.59K	Sell	138 -349	-72%	-$15.9K	﹤0.01%	1164
2023 Q2	$23.6K	Buy	487 +325	+201%	+$16.3K	﹤0.01%	809
2023 Q1	$7.98K	Hold	162	–	–	﹤0.01%	1011
2022 Q4	$8.2K	Hold	162	–	–	﹤0.01%	939
2022 Q3	$8K	Hold	162	–	–	﹤0.01%	932
2022 Q2	$8K	Sell	162 -4	-2%	-$203	﹤0.01%	905
2022 Q1	$10K	Sell	166 -2,775	-94%	-$175K	﹤0.01%	900
2021 Q4	$233K	Sell	2,941 -1,452	-33%	-$122K	0.04%	281
2021 Q3	$389K	Buy	+4,393	New	+$412K	0.06%	210

Other funds holding GNOM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

USCWA

U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

Armis Advisers Atlanta, Georgia $1.09B AUM 22.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SWA

Sightline Wealth Advisors Groton, Connecticut $236M AUM 12.89% 1-Year Est. Return

Creative Financial Designs's GNOM Position: Q1 2026 in Review

Creative Financial Designs reduced its Global X Genomics & Biotechnology ETF (GNOM) stake by 13% in Q1 2026, selling an estimated $72.3K and leaving 10,560 shares worth $462K. The position accounts for 0.03% of the portfolio, ranked #349.

Creative Financial Designs first reported a position in GNOM in Q3 2021 and has held it in 17 quarters since. The position peaked at $551K in Q4 2025. 40 funds tracked by Wall St. Rank hold GNOM as of Q1 2026.

Creative Financial Designs held 10,560 shares of Global X Genomics & Biotechnology ETF worth $462K as of Q1 2026.
Creative Financial Designs sold 1,564 Global X Genomics & Biotechnology ETF shares in Q1 2026, an estimated $72.3K.
Global X Genomics & Biotechnology ETF made up 0.03% of Creative Financial Designs's portfolio in Q1 2026, its #349 holding.
Creative Financial Designs first reported a position in Global X Genomics & Biotechnology ETF in Q3 2021 and has held it in 17 quarters since.
Creative Financial Designs's Global X Genomics & Biotechnology ETF position peaked at $551K in Q4 2025.
40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2026.

Based on Creative Financial Designs's 13F filing for Q1 2026, filed 13 Apr 2026.